0001104659-23-130581.txt : 20231229
0001104659-23-130581.hdr.sgml : 20231229
20231229191355
ACCESSION NUMBER: 0001104659-23-130581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myles Edward H
CENTRAL INDEX KEY: 0001358219
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38501
FILM NUMBER: 231529114
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scholar Rock Holding Corp
CENTRAL INDEX KEY: 0001727196
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823750435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-259-3860
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
tm2333989-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-29
0
0001727196
Scholar Rock Holding Corp
SRRK
0001358219
Myles Edward H
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
COO & CFO
1
Common Stock
2023-12-29
4
M
0
12459
4.86
A
181243
D
Common Stock
2023-12-29
4
S
0
12159
18.8157
D
169084
D
Common Stock
2023-12-29
4
S
0
300
19.5100
D
168784
D
Stock Option (Right to Buy)
4.86
2023-12-29
4
M
0
24914
0
D
2032-06-16
Common Stock
24914
49836
D
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2023.
Consists of 12,459 shares of common stock and 168,784 restricted stock units ("RSU").
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.24 to $19.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.25 to $19.64, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Consists of 168,784 RSUs and 300 shares of common stock.
Consists solely of RSUs.
Options shall vest and become exercisable in twelve quarterly installments over three years, with the first quarterly installment to vest on September 16, 2022 and each additional installment to vest quarterly thereafter, provided the individual continues to have a service relationship with the Company on such vesting date.
/s/ Junlin Ho, Attorney-in-Fact for Edward H. Myles
2023-12-29